Addressing Involuntary Movements in Tardive Dyskinesia
Clinical trial NCT02291861 · COMPLETED
Trial details
- NCT number
- NCT02291861
- Sponsor
- Auspex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-31
- Primary completion
- 2016-08-19
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.